Yu Akahoshi

1.4k total citations
64 papers, 521 citations indexed

About

Yu Akahoshi is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Yu Akahoshi has authored 64 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 19 papers in Oncology and 17 papers in Epidemiology. Recurrent topics in Yu Akahoshi's work include Hematopoietic Stem Cell Transplantation (39 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Yu Akahoshi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (39 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Yu Akahoshi collaborates with scholars based in Japan, United States and Ireland. Yu Akahoshi's co-authors include Shinichi Kako, Yoshinobu Kanda, Koji Kawamura, Hideki Nakasone, Miki Sato, Kiriko Terasako‐Saito, Misato Kikuchi, Kana Sakamoto, Tomotaka Ugai and Shun‐ichi Kimura and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Yu Akahoshi

58 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Akahoshi Japan	13	345	183	131	131	73	64	521
Masahiro Ashizawa Japan	14	321 0.9×	229 1.3×	157 1.2×	75 0.6×	106 1.5×	59	596
Colombe Saillard France	13	274 0.8×	176 1.0×	91 0.7×	143 1.1×	46 0.6×	34	515
Aki Tanihara Japan	15	247 0.7×	205 1.1×	176 1.3×	53 0.4×	105 1.4×	57	516
H.-J. Laws Germany	11	158 0.5×	172 0.9×	123 0.9×	72 0.5×	47 0.6×	20	429
Asao Hirose Japan	12	281 0.8×	148 0.8×	75 0.6×	63 0.5×	164 2.2×	70	496
Prassede Salutari Italy	13	220 0.6×	132 0.7×	80 0.6×	94 0.7×	88 1.2×	40	438
Clara Minotti Italy	13	199 0.6×	160 0.9×	142 1.1×	108 0.8×	24 0.3×	35	490
Kerstin Schaefer‐Eckart Germany	11	468 1.4×	225 1.2×	100 0.8×	141 1.1×	181 2.5×	23	831
Santhosh Thyagu Canada	11	220 0.6×	160 0.9×	80 0.6×	98 0.7×	58 0.8×	38	392
Barbara Holler Germany	10	330 1.0×	172 0.9×	79 0.6×	55 0.4×	165 2.3×	19	647

Countries citing papers authored by Yu Akahoshi

Since Specialization

Citations

This map shows the geographic impact of Yu Akahoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Akahoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Akahoshi more than expected).

Fields of papers citing papers by Yu Akahoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Akahoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Akahoshi. The network helps show where Yu Akahoshi may publish in the future.

Co-authorship network of co-authors of Yu Akahoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Akahoshi. A scholar is included among the top collaborators of Yu Akahoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Akahoshi. Yu Akahoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamaki, Masaharu, Yu Akahoshi, Yoshihiro Inamoto, et al.. (2024). Associations between acute and chronic graft-versus-host disease. Blood Advances. 8(16). 4250–4261.

Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations

Shimomura, Yoshimitsu, Takayoshi Tachibana, Yuho Najima, et al.. (2023). Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy. Blood. 142(Supplement 1). 4958–4958.

Tamaki, Masaharu, Yu Akahoshi, Yosuke Okada, et al.. (2023). Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients. Cytotherapy. 25(11). 1220–1228. 1 indexed citations

Shimomura, Yoshimitsu, Sho Komukai, Tetsuhisa Kitamura, et al.. (2023). Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide. Bone Marrow Transplantation. 59(1). 66–75. 2 indexed citations

Tamaki, Masaharu, Yu Akahoshi, Masahiro Ashizawa, et al.. (2023). Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation. Scientific Reports. 13(1). 7166–7166. 3 indexed citations

Nishiwaki, Satoshi, Yu Akahoshi, Hiroaki Shimizu, et al.. (2022). Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades. Blood Advances. 6(15). 4558–4569. 11 indexed citations

Konuma, Takaaki, Junya Kanda, Yachiyo Kuwatsuka, et al.. (2021). Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type. Clinical Cancer Research. 27(17). 4825–4835. 15 indexed citations

Takeshita, Junko, Shun‐ichi Kimura, Hideki Nakasone, et al.. (2021). Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 23(5). e13715–e13715. 3 indexed citations

10.

Nishiwaki, Satoshi, Yu Akahoshi, Shuichi Mizuta, et al.. (2021). Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2. Blood Advances. 5(2). 584–592. 6 indexed citations

11.

Tamaki, Masaharu, Hideki Nakasone, Junko Takeshita, et al.. (2021). Body Weight Loss Before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients. Transplantation and Cellular Therapy. 27(4). 340.e1–340.e6. 9 indexed citations

12.

Nakasone, Hideki, Machiko Kusuda, Kiriko Terasako‐Saito, et al.. (2021). Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation. Communications Biology. 4(1). 1177–1177. 2 indexed citations

13.

Kimura, Shun‐ichi, Junko Takeshita, Kazuki Yoshimura, et al.. (2020). Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 23(1). e13460–e13460. 3 indexed citations

14.

Tamaki, Masaharu, Hideki Nakasone, Junko Takeshita, et al.. (2020). Effect of Smoking on Outcomes of Allogeneic Transplantation: A Single-Center Analysis. Biology of Blood and Marrow Transplantation. 26(6). 1131–1136. 2 indexed citations

15.

Tachibana, Takayoshi, Yuho Najima, Yu Akahoshi, et al.. (2020). The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. Annals of Hematology. 99(10). 2393–2404. 5 indexed citations

16.

Nakasone, Hideki, Misato Kikuchi, Koji Kawamura, et al.. (2019). Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans. Scientific Reports. 9(1). 16499–16499. 2 indexed citations

17.

Akahoshi, Yu, Shuichi Mizuta, Hiroaki Shimizu, et al.. (2018). Additional Cytogenetic Abnormalities with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era. Biology of Blood and Marrow Transplantation. 24(10). 2009–2016. 16 indexed citations

18.

Hayakawa, J., Shun‐ichi Kimura, Ayumi Gomyo, et al.. (2018). Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 54(7). 994–1003. 17 indexed citations

19.

Ashizawa, Masahiro, Yu Akahoshi, Hirofumi Nakano, et al.. (2014). A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia. International Journal of Hematology. 99(3). 311–317. 5 indexed citations

20.

Matsuno, Fumihiko, H Matsuzaki, Yu Akahoshi, et al.. (1993). A Novel Ornithine Transcarbamylase Present in Mycoplasma-Infected Myeloma Cells. PubMed. 47(2). 57–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact